posts tagged:


lifescience


(search for keywords instead, or create an alert on this tag)

Tuesday, October 28, 2014

Bright.md Finds $1M for Health Software

Portland-based Bright.md, led by Ray Costantini and Mark Swinth, said this morning that it has raised a $1M, seed funding round for its health software. The funding came from Seven Peaks Ventures, along with the Portland Seed Fund and Orego...

READ MORE...
Monday, October 27, 2014

Limeade Gets $25M In New Funding

Seattle-based Limeade, a developer of software which helps employers improve the health of their employees, has raised $25M in a fudning round. The funding was led by Oak HC/FT Partners. TVC Capital also participated in the funding. Limeade...

READ MORE...
Tuesday, October 7, 2014

Cardiac Dimensions Adds $8.5M

Kirkland-based medical device developer Cardiac Dimensions said this morning that it has raised $8.5M in a financing round. The funding came from Arboretum Ventures, along with M.H. Carnegie & Co. and Lumira Capital. The funding is part of ...

READ MORE...
Tuesday, August 5, 2014

Juno Therapeutics Scores $134M More

Seattle-based biopharamceuticals developer Juno Therapeutics said this morning that it has raised $134M in a Series B funding. The funding came from ten public mutual funds and other healthcare-focused funds. Names of those exact investors ...

READ MORE...
Friday, July 25, 2014

Immune Design Flat After IPO

Seattle-based biotechnology company Immune Design is trading flat on the second day after its IPO, after debuting at $12.00 per share. The company priced at the low end of its earlier, estimated IPO range of $12.00 to $14.00 per share. Immu...

READ MORE...
Wednesday, July 23, 2014

Galena In Licensing Deal

Portland-based Galena Biopharma reported yesterday that the biopharmaceuticals firm is in a deal to license the rights for an oral soluble film from Monosol Rx. Galena is using MonoSol's PharmFilm oral soluble film technology for deliverin...

READ MORE...
Tuesday, July 22, 2014

X2 Biosystems Teams With Soccer League On Concussion Efforts

Seattle-based X2 Biosystems, which develops technology, software, and sensors around reducing the issues of sports related concussions, said today that it has partnered with a soccer league to test out its products with female youth soccer ...

READ MORE...
Monday, July 21, 2014

Cardiac Insight Finds $7M

Seattle-based Cardiac Insight, the University of Washington spinoff which is developing wearable sensors in the cardiology area, has raised $7M in a Series B funding. The funding came from Welch Allyn, WRF Capital, and other investors. Welc...

READ MORE...
Friday, July 18, 2014

DesignMedix Finds $1.5M

Portland-based DesignMedix, a developer of dual-action drugs which help combat drug resistance, has raised $1.5M in a funding round, according to the company. The funding came from the Portland Seed Fund, Bellingham Angels, Oregon Angel Fun...

READ MORE...
Tuesday, July 8, 2014

Adaptive Biotechnologies Names CTO

Seattle-based Adaptive Biotechnologies, which is using gene sequencing technology for clinical diagnostics, said today that it has named Sean Nolan as the company's Chief Technology OFficer. Nolan is a veteran of Microsoft, where he spent t...

READ MORE...
Thursday, June 26, 2014

Stratos Genomics Gets Strategic Investment From Roche

Seattle-based Stratos Genomics has received a strategic investment from Roche, the two announced today, to support the development of Stratos' DNA sequencing technology. Size of the investment was not announced. Stratos is led by Allan Step...

READ MORE...
Tuesday, April 29, 2014

Indi Finds $47.25M For Molecular Diagnostics Efforts

Seattle-based Indi, a developer of molecular diagnostics technology, said today that it has raised a total of $47.25M in a combination of equity and debt. The funding included $30.25M in a Series B equity fnding, and $17M in debt financing....

READ MORE...
Thursday, April 24, 2014

Juno Therapeutics Raises $176M

Seattle-based Juno Therapeutics announced this morning that it has raised $176M in a series A funding round, for its cancer immunotherapy efforts. According to the company, the funding came primarily from ARCH Venture Partners and the Alask...

READ MORE...
Wednesday, April 16, 2014

Cardiac Dimensions Lands $20M

Kirkland-based Cardiac Dimensions, which develops minimally invasive devices for treating heart failure, said today that it has raised $20M in a funding round. The funding was led by M. H. Carnegie & Co. and Lumira Capital, along with other...

READ MORE...
Tuesday, April 8, 2014

Adaptive Biotechnologies Scores $105M For Cancer Testing

Seattle-based Adaptive Biotechnologies has raised $105M in a Series D financing round, which all came from Viking Global Investors. The biotechnology company is working on sequencing technology being targeted at cancer immunotherapy. The co...

READ MORE...
Monday, March 31, 2014

Juno Therapeutics Taps Investment Banker As CFO

Seattle-based biotechnology developer Juno Therapeutics has turned to an investment banker from Morgan Stanley, to serve as Chief Financial Officer for the company. According to Juno Therapeutics, it has named Steve Harr, M.D., as Chief Fin...

READ MORE...
Tuesday, March 25, 2014

KinDex Pharmaceuticals Raises $5M

Seattle-based biopharmaceuticals developer KinDex Pharmaceuticals has raised $5M in a Series A funding. The funding was led by Polaris Partners. KinDex is specifically targeting Type 2 diabetes, using molecules which modulate regulatory net...

READ MORE...
Monday, February 10, 2014

Semler Scientific Drops Estimated IPO Range

Portland-based medical device developer Semler Scientific, which develops noninvasive devices used to measure arterial blood flow, has dropped its IPO range, saying in a filing last week that it now expects its IPO to be between $7.50 and $...

READ MORE...
Wednesday, February 5, 2014

Fluke Biomedical Buys Unfors RaySafe

Everett, Washington-based Fluke Biomedical, which manufactures biomedical test equipment and other scientific instrumentation, said today that it has acquired Unfors RaySafe. Unsors RaysSafe is a developer of diagnostic x-ray and dosage mon...

READ MORE...
Tuesday, February 4, 2014

Oregon Startup RevMedX's Technology May Pave Way To Stop Battlefield Deaths

An Oregon startup--RevMedX--has developed technology that might just help the military--and others--reduce deaths from gunshot wounds, by directly injects special clotting sponges into wounds on the battlefield. In an in-depth profile, Popu...

READ MORE...
Monday, January 13, 2014

NanoString Seeks $55M More In Secondary IPO

Seattle-based life sciences product developer NanoString Technologies said in a filing today that it plans to offer up $55M more in a secondary, public stock offering. The company said the new funds will go towards further commercialization...

READ MORE...
Monday, December 9, 2013

Clarity Health Services Lands $6.6M

Seattle-based Clarity Health Services, which provides healthcare care coordination services and technology, said Monday that it has raised $6.6M in a funding round. The round was led by Columbia Pacific Advisors' Opportunity Fund. The compa...

READ MORE...
Wednesday, December 4, 2013

Juno Lands Massive $120M Round For Cancer Research

Seattle-based Juno Therapeutics has raised an astounding, $120M in a Series A funding round today, to go towards the launch of a new company to develop immunotherapies for cancer. The startup--spun out of the Fred Hutchinson Cancer Research...

READ MORE...
Monday, December 2, 2013

Cell Therapeutics Gets $5M In Milestone Payment

Seattle-based Cell Therapeutics said this morning that it has received $5M, via a milestone payment from Teva Pharmaceutical Industrires. Cell Therapeutics said the pament was related to the achievement of a sales milestone for TRISENOX, wh...

READ MORE...
Thursday, November 21, 2013

NanoString Technologies Sets Bizdev Head

Seattle-based NanoString Technologies has named a new head of its business development efforts, the company announced Wednesday. The life sciences tool developer said it has named David W. Ghesquiere as Senior Vice President, Corporate & Bu...

READ MORE...
Tuesday, November 12, 2013

Dendreon Whacks 150 Employees

Seattle-based biopharmaceuticals developer Dendreon announced this morning that it has cut 150 jobs, or about 15 percent of its employees, as it looks to cut cash operating expenses at the company. The company--which has seen slipping sales...

READ MORE...
Wednesday, October 30, 2013

Immune Design Raises $49M

Seattle-based Immune Design announced this morning that it is raising up to $49M in a Series C funding round, split between an immediate investment of $32.5M upfront and an additional $16.5M in the near future, depending on program progress...

READ MORE...
Monday, October 21, 2013

Kona Medical Raises $10M For Kidney Treatment Device

Bellevue-based Kona Medical, the developer of ultrasound devices for treating kidney issues, said today that it has raised $10M in a Series D investment. The funding was led by Morningside Group, an investor focused on China, which is the r...

READ MORE...
Tuesday, October 8, 2013

Omeros Names VP

Seattle-based biopharmaceuticals firm Omeros announced this morning that it has appointed Michael K. Inouye as its new Vice President, Commercial Operations. Inouye was previously an executive at Pharmacyclics, and also has served at Telik,...

READ MORE...
Thursday, September 26, 2013

Immune Design Names Business Head

Seattle-based Immune Design said Thursday that it has named Stephen R. Brady as its Chief Business Officer. Brady was most recently CFO at 3-V Biosciences, and also has served at Proteolix, Lexicon Pharmaceuticals, Lazard Venture Advisors, ...

READ MORE...
Monday, September 23, 2013

Indi Molecular Gets $1.5M For Synthetic Antibodies

Seattle-based Indi Molecular, a developer of synthetic replacements for antibodies, has raised $1.5M in a seed funding round. The round was led by Interwest Partners, along with angels. The company--which has licensed technology from the Sc...

READ MORE...
Tuesday, September 3, 2013

Fate Therapeutics Approaches IPO, Sets IPO Range

Fate Therapeutics, the developer of stem cell technology which started in Seattle, is getting set for its IPO, saying in a regulatory filing this morning that it hopes to sell 4,000,000 shares of its common stock at between $14.00 and $16.0...

READ MORE...
Thursday, August 22, 2013

Tissue Regeneration Systems Raises $4.6M

Kirkland-based medical device firm Tissue Regeneration Systems has raised $4.6M in a funding round, the firm disclosed this week. The company said the funding came from Venture Investors. The company makes skeleton reconstruction implants u...

READ MORE...
Thursday, August 8, 2013

UW, GE Team To Develop Device To Detect Infections

Scientists at the University of Washington have teamed up with GE Global Research to work on developing paper-based, disposable devices for detecting infection and disease, the two announced Thursday. According to the two, they've developed...

READ MORE...
Wednesday, July 10, 2013

Mercury Medical Launches Medical Device Incubator In Bothell

A new, medical device incubator, Mercury Medical Technologies, has launched today in Bothell, according to the Bothell Biomedical Manufacturing Innovation Zone. According to the group, the new medical device incubator is housed at the Lake ...

READ MORE...
Wednesday, June 26, 2013

NanoString Walloped In IPO

Seattle-based NanoString Technologies, the provider of molecular diagnostics and other life sciences tools, was walloped in its IPO on Wednesday, closing down nearly 20 percent below its already low IPO price. The firm closed at $8.06 per s...

READ MORE...
Tuesday, June 25, 2013

Ignition Backs Keas For Corporate Wellness Service

Bellevue-based venture investor Ignition Partners has put more money behind a provider of a cloud-based, gamified, corporate wellness service this morning. Keas, which is based in San Francisco, said it has raised $8M in a new funding from ...

READ MORE...
Tuesday, June 18, 2013

Mirabilis Medica Gets $7M In Series A-1

Bothell-based Mirabilis Medica, a developer of ultrasound technology aimed at treating uterine fibroids, said Monday that i thas raised $7M in a Series A-1 funding, part of an ongoing $13M funding round. The funding was led by GSR Ventures,...

READ MORE...
Thursday, June 13, 2013

NanoString Sets IPO Range

Seattle-based NanoString Technologies looks like it's going to fast-track its path to an IPO, and has estimated its IPO trading range at between $13.00 and $15.00 per share. The company set its IPO range Thursday in a filing, also saying th...

READ MORE...
Thursday, June 6, 2013

Mobisante Gets $4.2M More

Redmond-based Mobisante, the developer of tablet-based, ultrasound technology, has raised $4.2M in an ongoing funding round. The firm disclosed the funding via a regulatory filing yestrday. The round is targeted at $5.3M. Details on the fun...

READ MORE...
Thursday, May 30, 2013

Oncothyreon Gets $10M In PIPE

Seattle-based biotechnology developer Oncothyreon disclosed this morning that it has raised $10M in a registered direct offering. The publicly held firm said it has agreed to sell 5,000,000 shares of its common stock and warrants to purchas...

READ MORE...
Thursday, May 23, 2013

EKOS Acquired By British Company

Seattle-based EKOS, the developer of ultrasound tools for treating vascular thrombosis, has been acquired by British biotech company BTG. BTG said it will pay $180M, plus up to $40M in earn out, for EKOS, whose products are used to treat se...

READ MORE...
Wednesday, May 22, 2013

Remote Medical International Finds $8M For Emergency Medicine

Seattle-based Remote Medical International, a provider of international medical services, said Thursday that it has raised $8M in a funding round. The funding came from Columbia Pacific Management, a Seattle investor which already owns 23 h...

READ MORE...
Monday, May 20, 2013

NanoString Files For IPO

Seattle-bsaed life sciences and molecular analysis systems developer NanoString Technologies has filed for an IPO, saying this morning in a filing that it hopes to raise $86.25M in the offering. The firm has applied to list as NSTG on the N...

READ MORE...
Wednesday, May 1, 2013

Square 1 Bank Bolsters Seattle Presence

Square 1 Bank, a specialized technology banks, said Wednesday that it has bolstered its Seattle presence, to help grow the company's business in the Pacific Northwest. According to Square 1 Bank, Rilus Graham has relocated to Seattle to gro...

READ MORE...
Tuesday, April 16, 2013

BEAT BioTherapeutics Raises $2.5M In Seed Funds For Heart Treatment

Seattle-based BEATbio, a biotechnology firm which says it is looking to develop a novel gene therapy to improve cardiac performance during heart failure, has raised $2.5M in a seed funding round. The firm said the funding came from CET Capi...

READ MORE...
Wednesday, April 10, 2013

Mobisante Debuts Tablet-based Ultrasound

What do you get when you cross a tablet PC with an ultrasound system? Redmond-based medical imaging systems developer Mobisante has rolled out a tablet-based, ultrasound imaging system, which it says lets healthcare providers conduct ultras...

READ MORE...
Thursday, March 28, 2013

Atossa Genetics Gets $30M In PIPE

Seattle-based Atossa Genetics said Thursday that it has raised $30M more, in a stock purchase agreement with Aspire Capital. The publicly held firm, which is developing diagnostics for breast cancer, said Aspire paid $12.00 per share for $1...

READ MORE...
Monday, March 25, 2013

Theraclone Sciences Snags $14M More

Seattle-based therapeutic antibody developer Theraclone Sciences said this morning that it has raised $14M, in a combination of equity and debt funding. The firm said that $8M of the funding was equity, which came from its existing investor...

READ MORE...
Friday, March 15, 2013

Syntrix Biosystems Wins $96M In Patent Lawsuit

Auburn, Washington-based Syntrix Biosystems has scored a big jury award as part of a patent infringement lawsuit, according to life sciences equipment maker Illumina. Illumina said it was ordered to pay the damages to Syntrix, based on a ro...

READ MORE...
Friday, February 22, 2013

Blaze Biosciences Raises $8.5M

Seattle-based Blaze Bioscience announced this morning that it has raised $8.5M in a Series A funding round. The firm said the funding came from individual investors, including physicians and biotech executives. The firm said it has now rais...

READ MORE...
Wednesday, February 20, 2013

EndoGastric Solutions Raises $10.0M

Redmond-based EndoGastric Solutions, a developer of medical devices used for treating gastrointestinal diseases, has raised $10.0M more in funding, according to a regulatory filing. Details on the funding have yet to be announced. EndoGastr...

READ MORE...
Tuesday, February 12, 2013

Innovative Pulmonary Solutions Raises $10M, But Moves To Minnesota

Bellevue-based Innovative Pulmonary Solutions said today that it has raised $10M in a Series C funding round--but has moved its headquarters to Minneapolis, Minnesota from Bellevue, and renamed itself to Holaira. The medical device company,...

READ MORE...
Wednesday, February 6, 2013

Kineta Finds New Funding

Seattle-based Kineta, the biopharmaceuticals firm developing treatments for infection and autoimmune diseases, said yesterday that it has scored a new investment from RLB Holdings, the investment group which also owns the New York Yankees. ...

READ MORE...
Monday, February 4, 2013

CareSimple Launches To Let You Talk To Doctors, Nurses Via Skype, Webcam

How do you more easily connect with a doctor or nurse about your health? A new service, CareSimple from Seattle-based Carena, is looking to make talking to a doctor or nurse as easily as calling them up on Skype. Accordin to Carena, its new...

READ MORE...
Wednesday, January 30, 2013

FlexMinder Raises $1.4M

Seattle-based Flexminder, a provider of services to help third party health administrators automate flexible spending account claim submissions, has raised $1.4M in a funding round. The round came from Founder's Co-Op, WRF Capital, and othe...

READ MORE...
Friday, January 4, 2013

Qliance Lands $8.65M More For Health Clinics

Seattle-based Qliance, the venture-backed operator of primary care clinics for preventative care, minor treatments, and treating chronic health conditions, has raised $8.65M in a new investment, according to a regulatory filing from the com...

READ MORE...
Wednesday, December 19, 2012

Madrona's Latest Investment: High Tech Back Pain Help

Can a high tech device help you avoid back pain? That's the idea behind Seattle-based Madrona Venture Group's latest investment, LUMO BodyTech. LUMO said Wednesday that Madrona led its $5M Series A funding round, which also included Innovat...

READ MORE...
Wednesday, December 5, 2012

Kona Medical Adds $10M

Bellevue-based medical devices developer Kona Medical said yesterday that it has added $10M in equity and debt as part of its Series C financing round, bring its total raised in the round to $40M. The firm said it added two, un-named large-...

READ MORE...
Monday, December 3, 2012

NanoString Technologies Gets $15.3M

Seattle-based NanoString Technologies, which develops life science tools for the molecular diagnostics area, said this morning that it has raised $15.3M in a Series E funding round. The round came from Morgan Stanley Expansion Capital and A...

READ MORE...
Monday, November 12, 2012

Visterra Finds Funding From Gates Foundation

Visterra, a biopharmaceuticals developer focusing on novel medicines to prevent and treat infections, said last week that it has raised $26M in a Series A round, led by the Bill and Melinda Gates Foundation. The funding also include Omega F...

READ MORE...
Monday, November 5, 2012

Advanced Microscopy Group Acquired By Life Technologies

Bothell-based Advanced Microscopy Group, which develops imaging systems for research microscopy, has been acquired by life sciences equipment company Life Technologies. Financial terms of the acquisition were not announced. Life Technologie...

READ MORE...
Thursday, November 1, 2012

Resolve Therapeutics Finds $5.8M

Seattle-based Resolve Bio has raised $5.8M more for its efforts to develop treatments for lupus, according to a report today. The funding came from WRF Capital, New Science Ventures, and Easton Capital. New of the funding first came from Xc...

READ MORE...
Wednesday, October 3, 2012

NanoString Sets New CFO

Seattle-based lifesciences tool developer NanoString Technologies said this morning that it has named James A. Johnson as its new Chief Financial Officer. Johnson joins the firm from Relypsa, where he also served as CFO' he also has been at...

READ MORE...
Friday, September 21, 2012

Innovative Pulmonary Solutions Gets $10.6M

Bellevue-based medical device developer Innovative Pulmonary Solutions has raised $10.6M in a Series B funding round, the firm announced Thursday. The funding came in March of 2012, and was led by Advanced Technology Ventures. Other investo...

READ MORE...
Monday, September 10, 2012

ZocDoc Heads To Portland

ZocDoc, which operates a service which helps users to book doctor's appointments over the Internet, said today that it has arrived in Portland. The startup--which is venture backed by Jeff Bezos and his firm, Bezos Expeditions--has been ava...

READ MORE...
Wednesday, August 29, 2012

Matrix Genetics Gets Funding From Biofuel Efforts

Seattle-based Matrix Genetics, a biotechnology firm aimed at producing both renewable fuels and specialty chemicals from algae, said today that it has scored a funding round. The round came from Avista Development, the Spokane-based venture...

READ MORE...
Wednesday, July 18, 2012

NanoString Technologies Names Board Member

Seattle-based NanoString Technologies, the developer of molecular diagnostic tools, said this morning that it has named a new member to its board. The company said it has named Greg Norden, the former Chief Financial Officer of Wyeth, to th...

READ MORE...
Thursday, June 28, 2012

Carena Finds $14M

Seattle-based Carena, a provider of virtual medicine services which provides patients with around-the-click access to registered nurse practitioners via telephone, webcam, and in-person house calls, has raised $14M in a funding round. The f...

READ MORE...
Friday, June 8, 2012

Blaze Bioscience Gets $5M For Tumor Paint

Seattle-based Blaze Bioscience, a developer of technology it calls "tumor paint" to help physicians visualize solid, cancer tumors, has raised $5.0M in a Series A financing round, the firm said today. Source of the funding was not announced...

READ MORE...
Wednesday, May 30, 2012

Kona Medical Gets $30M In Series C

Bellevue-based Kona Medical, a developer of ultrasound-based treatments for high blood pressure, said Wednesday that it has raised $30M in a Series C funding round. The round came from existing Essex Woodlands, Domain Associates, Morgentha...

READ MORE...
Tuesday, May 29, 2012

NanoString Names VP, GM

Seattle-based NanoString Technologies, the developer of life sciences tools used for molecular diagnostics, said today that it has named Bruce J. Seeley as its Senior Vice President and General Manager, Diagnostics. Seeley joins the firm fr...

READ MORE...
Wednesday, May 16, 2012

Medify Acquired By Alliance Health

Seattle-based Medify, which operates an online site which allows users to learn more about health conditions via the experiences of other patients, has been acquired by healthcare social networking provider Alliance Health Networks. Financi...

READ MORE...
Thursday, April 26, 2012

Cadence Biomedical Raises $1.1M

Seattle-based Cadence Biomedical, a developer of medical devices to help people with severe disabilities to walk, said this morning that it has raised $1.1M in a Series A2 funding round. The funding came from the Sand Hill Angels, Tech Coas...

READ MORE...
Thursday, April 19, 2012

Alder BioPharmaceuticals Lands $38M

Bothell-based Alder BioPharmaceuticals, a developer of technology for developing antibodies used in treating cancer, autoimmune diseases, and other diseases, has raised $38M in a Series D funding round, the company said this morning. The fu...

READ MORE...
Friday, March 30, 2012

Talyst Partners With Software Firm

Bellevue-based Talyst, the developer of pharmacy automation tools, reported Thursday that it has partnered with healthcare software firm Medacist Solutions Group. According to the two, Medacist Solutions Group will offer its software to sup...

READ MORE...
Friday, March 30, 2012

SonoSite Acquisition By Fujifilm Completes

The acquisition of Bothell-based SonoSite, the provider of ultrasound technology, has completed, FujiFilm said this morning. FujiFilm had said it would pay $995M for SonoSite in December, paying $54.00 per share in cash for the maker of ult...

READ MORE...
Thursday, March 29, 2012

Amazon Ties With NIH on Genomics Research Effort

Seattle-based Amazon Web Services, the web services arm of Amazon.com, said today with the United Stations National Institutes of Health (NIH), that the two have collaborated on publishing a major human genetics database on the web. The ser...

READ MORE...
Wednesday, March 21, 2012

Paul G. Allen Invests $300M More In Brain Institute

Microsoft billionaire Paul G. Allen is investing an additional, $300M in funding towards the Allen Institute for Brain Science, the institute said Wednesday, putting the total invested in the brain research outfit at $500M. According to the...

READ MORE...
Monday, March 12, 2012

HemaQuest Pharmaceuticals Taps Into $13M More

HemaQuest Pharmaceuticals, which is developing small molecule therapeutics for treating hemoglobain disorders such as sickle cell disease, said today that it has raised $13M in a Series B extension financing. The firm, which has its researc...

READ MORE...
Wednesday, March 7, 2012

PHACTS Acquired By CareFusion

Seattle-based PHACTS, a provider of pharmacy automation technology and consulting, has been acquired by pharmacy automation software firm CareFusion. PHACTS provides consulting and software to help pharmacies better manage their inventory a...

READ MORE...
Wednesday, February 22, 2012

Integrated Diagnostics Lands $10M

Seattle-based Integrated Diagnostics, the developer of molecular diagnostic products, said this morning that it has closed on $10M in a third tranche of its Series A financing. The funding was led by Interwest Partners, and also included Th...

READ MORE...
Wednesday, February 8, 2012

Bend Research Inks Deal With Eli Lilly

Bend, Oregon-based Bend Research, a provider of drug-formulation development and manufacturing services, said today that it has inked a deal with Eli Lilly and Company. According to Bend Research, it is making its proprietary spray-dried di...

READ MORE...
Tuesday, February 7, 2012

Vulcan Capital Backs Personalized Medicine Firm

Seattle-based Vulcan Capital is one of the investors in a developer of personalized medicine products. According to Applied Proteomics, which is based in San Diego, California, Vulcan joined Domain Associates and un-named angels in investin...

READ MORE...
Thursday, February 2, 2012

Hubbub Health Launches To Spur Healthy Lifestyles

Portland-based Cambia Health Solutions, which operates a portfolio of health care information, software, insurance, and other health related companies, said today that it has launched Hubbub Health, a new online service to spur people to li...

READ MORE...
Monday, January 30, 2012

Physio-Control Sale Closes

The acquisition of Redmond-based Physio-Control, the maker of automatic external defibrillators (AEDs), by private equity firm Bain Capital has completed, Physio-Control said today. The deal had been announced in November. The deal was wort...

READ MORE...
Monday, January 9, 2012

Uptake Medical Raises Funding Round

Uptake Medical, the developer of treatment for emphysema, has raised a Series C round of funding, the firm said this morning. The company--which has offices in Seattle, but which recently moved its headquarters to Southern California--did n...

READ MORE...
Friday, January 6, 2012

Oncothyreon Names Chief Medical Officer

Seattle-based Oncothyreon, which is developing treatments for cancer, said yesterday that it has promoted Diana Hausman, M.D., to the position of Chief Medical Officer. Hausman has been Vice President, Clinical Development at the firm since...

READ MORE...
Thursday, December 15, 2011

SonoSite Acquired By Fujifilm For $995M

Bothell-based ultrasound maker SonoSite is being acquired by Fujifilm Holdings in a deal worth $995M, according to the companies this morning. Fujifilm and Sonosite said that Fufijilm will acquire SonoSite for $54 per share in cash, or appr...

READ MORE...
Monday, December 12, 2011

AVI Biopharma Chops 28 Percent

Bothell-based AVI Biopharma, which develops RNA-based therapeutics for rare and infectious diseases, said late Friday that it has chopped its workforce by approximately 28 percent, as part of an effort to "streamline" the firm's infrastruct...

READ MORE...
Monday, December 12, 2011

Groove Biopharma Lands $6M

Seattle-based Groove Biopharma, a biopharmaceuticals startup focused on microRNA, said Monday that it has raised $6M in a Series B funding. The firm--formerly known as Mirina--said the funding came from Alexandria Venture Investments, ARCH ...

READ MORE...
Monday, December 12, 2011

Applied Precision Licenses Patents From Yale

Issaquah, Washington-based Applied Precision, which develops microscopic imaging products, reported this morning that it has licensed a new set of patents from Yale University. The company did not discuss terms of the license, but said the ...

READ MORE...
Thursday, December 8, 2011

Talyst Launches Mobile App

Bellevue-based Talyst, the developer of pharmacy automation tools, said today that it has launched a mobile app for iOS, which connects to the firm's pharmacy management systems. The firm said the new app, AutoPharm Mobile, provides real ti...

READ MORE...
Monday, December 5, 2011

Talyst Announces New Product

Bellevue-based Talyst, the developer of pharmacy automation products headed by Carla Corkern, said today that it has launched a new, automated storage and pharmacy-grade refrigeration system. The firm said its new AutoCarousel HD software h...

READ MORE...
Thursday, November 17, 2011

Medtronic Sells Physio-Control To Bain Capital

Redmond-based Physio-Control, the provider of defibrillators and other emergency medical equipment, which is a unit of Medtronic, is being sold to private equity firm Bain Capital. Medtronic, which is based in Minneapolis, said it would sel...

READ MORE...
Friday, November 11, 2011

Clarisonic Maker Pacific Bioscience Laboratories Acquired By L'Oreal

Redmond-based Pacific Bioscience Laboratories, the developer of the Clarisonic skin care devices, has been acquired by L'Oreal USA, the firms said Thursday afternoon. Financial terms of the buy were not disclosed. Pacific Bioscience Laborat...

READ MORE...
Friday, October 21, 2011

Impel NeuroPharma Raises $500K In Series B

Seattle-based Impel Neuropharma, a developer of biomedical devices, has raised $500,000 in a Series B, angel funding round, the firm said Thursday. Names of those angel investors were not detailed. Impel Neuropharma is developing a medical ...

READ MORE...
Wednesday, October 19, 2011

VisionGate Raises $2M For Lung Cancer Detection

VisionGate, a developer of non-invasive tests for lung cancer, said today that it has raised $2M out of a $3M funding round. The firm, which has research and development offices in Seattle near the University of Washington, did not disclose...

READ MORE...
Tuesday, October 18, 2011

Immune Design Names Exec

Seattle-based Immune Design Corp., a biotechnology firm focused on molecular immunology, said today that it has named Guy F. Cipriani as its Chief Business officer. Cipriani was most recently at Cardiome Pharma Corp., and also has served at...

READ MORE...
Tuesday, September 20, 2011

Calypso Medical Technologies Acquired

Seattle-based Calypso Medical Technologies, the developer of real-time tumor tracking systems for the radiosurgery and radiotherapy market, has been acquired by Varian Medical Systems, the two firms said Tuesday. Varian will pay approximate...

READ MORE...
Tuesday, September 13, 2011

RF Surgical Systems Finds $12M

Bellevue-based RF Surgical Systems, a developer of systems used to keep track of surgical sponges within patients, said Tuesday that it has raised $12M in a new fundraising round. The round was led by Split Rock Partners, and also included ...

READ MORE...
Thursday, September 8, 2011

Theraclone Sciences Snags $10.6M More In Series B

Seattle-based Theraclone Sciences, a biotechnology firm focused on developing therapeutic antibodies for treating infectious disease and cancer, said Thursday that it has raised $10.6M in a Series B funding round. The round came from prior ...

READ MORE...
Thursday, September 8, 2011

Dendreon Whacks 500

Seattle-based Dendreon, the developer of a drugs used to boost the immune systems of prostate cancer patients, said Thursday afternoon that it is laying off 500 of its employees, in the face of sales issues for its drug. The firm said that ...

READ MORE...
Thursday, September 1, 2011

Pathway Medical Acquired By Bayer Healthcare

Kirkland, Washington-based Pathway Medical Technologies, a developer of products for treating Peripheral Arterial Disease (PAD), has been acquired by Bayer Healthcare. Financial terms of the buy were not disclosed. Bayer said the acuqisitoi...

READ MORE...
Tuesday, August 30, 2011

Amnis Acquired By EMD Millipore

Seattle-based Amnis Corporation, which manufacturer advanced cell imaging systems for the life sciences market, has been acquired by German firm EMD Millipore, the Life Science division of Merck KGaA. Financial terms of the acquisition were...

READ MORE...
Monday, July 18, 2011

Microsoft Targets Google Health Users

Redmond-based Microsoft Corp. is looking to siphon off users of Google Health, saying today that it will make it easy for users to migrate their health data from Google Health to Microsoft's own HealthVault service. Google said in June that...

READ MORE...
Thursday, July 14, 2011

Spacelabs Healthcare Launches New Product

Issaquah-based Spacelabs Healthcare said today that it has launched a new product. The firm said it has launched the Sonicaid Encore, a high performance fetal and maternal monitor, which uses ultrasound to locate and track fetal heartbeat a...

READ MORE...
Monday, June 27, 2011

Atossa Raises $6.6M For Molecular Diagnostics

Seattle-based Atossa Genetics, a developer of molecular diagnostics for breast cancer, said this morning that it has raised $6.6M in a new funding round. Source of the new funding was not announced. The firm said the round was oversubscribe...

READ MORE...
Thursday, June 9, 2011

Stratos Adds $2.1M For Gene Sequencing Technology

Seattle-based Stratos Genomics said Wednesday that it has raised $2.1M in a new round of funding. The firm said the funding came from existing investors. The funding will go to continue development of the firm's DNA sequencing method, aimed...

READ MORE...
Tuesday, May 17, 2011

Resolve Therapeutics Gains $2M

Seattle-based Resolve Therapeutics, a new startup developing treatments for lupus, said today that it has raised $2M in a initial close of a Series A funding round. The round came from New Science Ventures and Easton Capital. Resolve Therap...

READ MORE...
Tuesday, May 17, 2011

Talyst Wins Medical Center

Bellevue-based Talyst, a developer of pharmacy automation products, has signed on a hospital in New Jersey. The Hackensack University Medical Center (HUMC) said today that it has implemented the AutoCarousel HD by Talyst, a secure automated...

READ MORE...
Tuesday, May 3, 2011

VacuPractor Wins $25K From ZINO Society

Redmond-based VacuPractor, a developer of a device for lower back pain treatment, has scored $25,000 from the ZINO Life Fund, the ZINO Society said Monday evening. The ZINO Society said the funding came out of a presentation at the March li...

READ MORE...
Monday, May 2, 2011

Avvo Looks To Bolster Doctor Reviews With Charity Link

Seattle-based Avvo, the online directory of doctors and lawyers, is looking to spur more reviews of doctors on the site with a link to a charity. According to Avvo, it will donate $5 to the Melanoma Research Foundation for every doctor revi...

READ MORE...
Thursday, April 28, 2011

Applied Precision Acquired By GE Healthcare

Issaquah, Washington-based Applied Precision, a developer of cellular imaging products for the cell biology and biomedical research market, has been acquired by GE Healthcare, a unit of GE. Financial details of the deal were not disclosed. ...

READ MORE...
Friday, April 15, 2011

Talyst Wins Pharmaceutical Wholesaler

Bellevue-based Talyst, a developer of pharmacy automation products, said earlier this week that it has signed pharmaceutical wholesaler H.D. Smith as a customer. Talyst said that H.D. Smith is the fourth largest pharmaceuticals wholesaler i...

READ MORE...
Tuesday, March 29, 2011

Frazier Healthcare Buys Unit of CareFusion

Seattle-based venture capital firm Frazier Healthcare has completed its acquisition of the Onsite Services unit of CareFusion, the firms said Tuesday. The deal had been announced on January 11th. CareFusion's OnSite SErvices arm provides me...

READ MORE...
Wednesday, March 2, 2011

Physio-Control Buys Swedish Firm

Redmond-based Physio-Control, which makes debrillators, said yesterday that it has acquired Jolife AB, a maker of a chest compression device for CPR. Financial terms of the deal were not disclose. Jolife AB is headquartered in Lund, Sweden....

READ MORE...
Tuesday, February 22, 2011

Calistoga Pharmaceuticals Acquired For $375M

Seattle-based Calistoga Pharmaceuticals, a developer of medicines to treat cancer and inflammatory diseases, has been acquired by Gilead Sciences in a $375M deal. According to the two firms, they are in a definitive agreement where Gilead w...

READ MORE...
Tuesday, February 22, 2011

Inovise Scores $4.4M More

Beaverton, Oregon-based Inovise, a developer of medical instruments being used for cardiology, has raised $4.4M in an ongoing, $5.0M funding round, according to a recent regulatory filing from the firm. No details on the funding have been a...

READ MORE...
Tuesday, February 22, 2011

Microsoft, athenahealth Link On Health Communications

Redmond-based Microsoft has linked its enterprise health intelligence software, Microsoft Amalga, with web-based practice management firm Athenahealth, the two said this morning. The two said they are in a strategic alliance which will conn...

READ MORE...
Monday, February 14, 2011

Ricera Biosciences Sells Bothell Unit

Ricera Biosciences, LLC has sold its Efficacy Pharmacology operating unit, which is based in Bothell, Washington, to contract research firm Numira Biosciences. Numira said that it has acquired laboratory operations in Bothell, Washington, t...

READ MORE...
Thursday, February 10, 2011

Geospiza Gets $1.2M SBIR Grant

Seattle-based Geospiza, the developer of software for the genetic analysis market, reported today that it has received a $1.2M phase II SBIR grant from the National Institutes of health. The firm said the grant will go towards developing a ...

READ MORE...
Wednesday, February 9, 2011

Physio-Control Partners With BeneChill

Redmond-based Physio-Control, the developer of defibrillators used for treatment of sudden cardiac arrest, said today that it has inked a strategic partnership with BeneChill, a developer of therapeutic cooling systems. BeneChill's products...

READ MORE...
Friday, January 28, 2011

PhysioSonics Gains Series B

Seattle-based PhysioSonics, a firm developing noninvasive neurological monitors, said this week that it has scored a Series B funding round. The round was led by Kirby Cramer, former Chairman of SonoSite, as well as undisclosed strategic in...

READ MORE...
Thursday, January 27, 2011

Calypso Medical Names President and CEO

Seattle-based Calypso Medical Technologies, a developer of technology to track tumors, announced yesterday that it has named Edward Vertatschitsch as its President and CEO. Vertatschitsch has been at the firm since 2003, and was most recent...

READ MORE...
Tuesday, December 7, 2010

Kryptiq Wins South Carolina Firm

Portland-based Kryptiq, a provider of healthcare software, reports today that South Carolina Oncology Associates (SCOA), has implemented its online bill payment software. Financial details of the win were not disclosed. Kryptiq said SCOA op...

READ MORE...
Monday, November 8, 2010

OncoGenex Pharmaceuticals Names CFO

Bothell-based OncoGenex Pharmaceuticals said this morning that it has named Michelle Burris as Executive Vice President, Operations, and Chief Financial Officers. Burris is currently a member of the firm's board, and previously served at SV...

READ MORE...
Monday, November 1, 2010

Uptake Medical Names VP

Seattle-based Uptake Medical, a developer of treatments for emphysema, said today that it has named Dr. Steven Kesten as its Vice President and Chief Medical Officer. Uptake said that Dr. Kesten has previously served at Boehringer Ingelheim...

READ MORE...
Wednesday, October 27, 2010

Mebik.org Takes On Healthcare Prices

Seattle-based Mebik.org, a new, online resource focused on medical costs, said today that it has launched a new site which translates medical terms and codes into common language, and also helps people find local medical cost information. T...

READ MORE...
Tuesday, October 26, 2010

Immune Design Licenses Technology To MedImmune

Seattle-based Immune design Corp., a developer of immunotherapies and vaccines for infectious diseases and cancer, said today that it has entered into a license and development agreement with MedImmune. Financial details of the licensing de...

READ MORE...
Tuesday, October 26, 2010

Omeros Gets $25M

Seattle-based Omeros Corporation, the biopharmaceuticals firm focused on treating inflammation and disorders of the central nervous system, said yesterday that it has raised $25M, including $20M from Vulcan Capital, and $5M in a grant from ...

READ MORE...
Monday, September 27, 2010

Office Ally Targets Insurance Reimbursement

Vancouver, Washington-based Office Ally, a provider of electronic healthcare and other software for physicians and hospitals, said this morning that it has launched a new billing service for healthcare providers. According to the firm, its ...

READ MORE...
Wednesday, September 22, 2010

Geospiza Wins European DNA Sequencing Firm

Seattle-based Geospiza, a developer of gene sequencing tools, has inked a deal with European DNA sequencing services provider Eurofins MWG Operon. According to the firms, Eurofins is using Geospiza's GeneSifter Lab Edition to manage all of ...

READ MORE...
Tuesday, September 7, 2010

SweetSpot Diabetes Care Raises Funds

Portland, Oregon-based SweetSpot Diabetes Care, a startup focus on using data from patient devices to improve diabetes care, said Tuesday that it has raised a round of initial funding. Amount of the funding was not disclosed. The round came...

READ MORE...
Tuesday, September 7, 2010

ZymoGenetics Acquired By Bristol-Myers Squibb

Seattle-based ZymoGenetics, a developer of biotherapeutics for treating hepatitis C and metastatic melanoma, along with other disorders, is being acquired by Bristol-Myers Squibb. According to the firms, the deal is worth $9.75 per share in...

READ MORE...
Tuesday, September 7, 2010

Stratos Genomics Raises $4M

Seattle-based Stratos Genomics, a developer of DNA sequencing equipment for genome analysis and molecular diagnostics, announced Tuesday afternoon that it has raised $4M in a Series A funding. According to the firm, the round was led by Fis...

READ MORE...
Tuesday, August 31, 2010

Geospiza Links With SAIC-Frederick

Seattle-based Geospiza, the developer of software for managing genetic analysis workflows, said Tuesday that it is in a collaboration with SAIC-Frederick Inc., a technical support contractor for the National Cancer Institute's research and ...

READ MORE...
Monday, August 30, 2010

EndoGastric Solutions Gets $30M More

Redwood City-based EndoGastric Solutions, a developer of treatments for upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD), announced today that it has raised $30M in a Series F financing round. The firm also ...

READ MORE...
Monday, August 16, 2010

Blue Heron Acquired By Origene

Bothell-based Blue Heron, a provider of gene synethesis services, has been acquired, according to Origene. According to Origene, which is a life sciences firm based in Rockville, Maryland, it acquired Blue Heron to expand its gene-centric t...

READ MORE...
Thursday, August 12, 2010

Trubion Pharmaceuticals In Acquisition Deal

Seattle-based Trubion Pharmaceuticals said Thursday afternoon that it is in a definitive merger agreement with Emergent BioSolutions. According to the firm, the deal is worth approximately $96.8M up front, consisting of a $1.365 per share c...

READ MORE...
Wednesday, July 28, 2010

Hemaquest Raises $4M

Seattle-based HemaQuest Pharmaceuticals, a firm developing small molecule therapeutic treatments for sickle cell disease, beta thalassemia, and cancer, said today that it has raised and additional $4M in its Series B round, bringing the tot...

READ MORE...
Monday, July 26, 2010

Immune Design Raises $32M

Seattle-based Immune Design Corp., a biotech firm focused on treatments for infectious disease and cancer, said today that it has raised $32M in a Series B funding round. The round was led by ProQuest Investments, and also included current ...

READ MORE...
Thursday, July 22, 2010

Integrated Diagnostics Gets $10M

Seattle-based Integrated Diagnostics, the medical diagnostics firm founded by genome pioneer Dr. Leroy Hood, said today that it has raised $10M in a second tranche of its Series A funding. The firm said the move came due to "substantial pro...

READ MORE...
Wednesday, July 7, 2010

Uptake Medical Gets $17.5M

Seattle-based Uptake Medical, a developer of medical devices for treating emphysema, announced today that it has raised $17.5M in a Series B funding round. The round was led by Maverick Capital, and also included prior investors GBS Venture...

READ MORE...
Wednesday, June 30, 2010

SonoSite Completes VisualSonics Buy

Bothell-based SonoSite said Wednesday that it has completed its acquisition of Toronto-based ultrasound firm VisualSonics. The deal was worth $67.9M, net cash and debt. SonoSite said VisualSonics will become a wholly owned subsidiary of the...

READ MORE...
Wednesday, June 30, 2010

Calistoga Pharmaceuticals Gains $40M More

Seattle-based Calistoga Pharmaceuticals, a developer of treatments for cancer and inflammatory disease, said today that it has raised $40M more in a Series C financing round. The round was led by Quogue Capital, and also included prior inve...

READ MORE...
Tuesday, June 29, 2010

NanoString Names Execs

Seattle-based NanoString Technologies said this morning that it has named Brad Gray as its President and CEO, and Nalini Murdter, Ph.D. as its Chief Business Officer. Gray joins from Genzyme Genetics, and also has served at McKinsey & Compa...

READ MORE...
Thursday, June 24, 2010

Presage Biosciences Ups Funding To $3.8M

Seattle-based Presage Biosciences, the spinout of the Fred Hutchinson Cancer Research Center, has upped its total funding to $3.8M, up from the $3.1M the firm announced in March. The additional funding was revealed through a regulatory fili...

READ MORE...
Monday, June 7, 2010

Kineta Gets Investment From Iacocca Family

Seattle-based Kineta, a firm developing biopharmaceutiacls to treat Type 1 diabetes, reported today that it has inked a new investment partnership with The Iacocca Family Foundation, to speed development of its compounds. Financial terms of...

READ MORE...
Thursday, May 27, 2010

SonoSite Buys Visualsonics

Bothell, Washington-based Sonosite announced today that it has agreed to acquire Visualsonics, a developer of ultra high frequency micro-ultrasound technology. The deal is worth $71M in cash and debt. Sonosite said that Visualsonics' techno...

READ MORE...
Thursday, April 29, 2010

Schrodinger Gets Funding

Portland-based Schrodinger, a firm focused on computational drug design for the pharmaceuticals and biotechnology research industry, said today that it has scored an investment from Cascade Investment, LLC, the investment firm of Bill Gates...

READ MORE...
Monday, April 26, 2010

Mirina Gets Funding

Seattle-based Mirina Corporation, a biotechnology firm focused on microRNA therapeutics, said today that it has closed on a Series A-1 financing. Size of the round was not disclosed. According to Mirina, the round was led by versant Venture...

READ MORE...
Tuesday, April 20, 2010

Seattle Genetics Gets $9.5M From Genentech

Bothell-based Seattle Genetics, a biotechnology firm developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease, reported this morning that it will receive $9.5M in a payment from Genentech, as part of...

READ MORE...
Wednesday, April 14, 2010

Signature Genomic Laboratories Acquired By PerkinElmer

Spokane-based Signature Genomic Laboratories, a provider of diagnostic genetic testing services, has been acquired by PerkinElmer, PerkinElmer said today, in a deal worth $90M. According to PerkinElmer, the acquisition will strengthen the f...

READ MORE...
Monday, April 12, 2010

Liberty Dialysis Gets Private Equity Backing

Mercer Island-based Liberty Dialysis, which operates a network of dialysis centers, has scored new funding from private equity firm KRG Capital Partners, Bain Capital Ventures, and Ignition, according to KRG. According to the firm, the fund...

READ MORE...
Thursday, April 8, 2010

Dendreon Appoints VP

Seattle-based Dendreon announced today that it has added Varun Nanda as its Senior Vice President of Global Operations. Nanda joins the firm from Roche/Genentech, where he was Senior Vice President and Global Head of Oncology. Nanda has als...

READ MORE...
Thursday, April 1, 2010

MDRNA Acquires Cequent Pharmaceuticals

Bothell-based MDRNA said Thursday that it has acquired Cequent Pharmaceuticals, a developer of RNAi-based therapeutics, in a deal worth $46M in stock. According to MDRNA, the acquisition will expand its oncology pipeline, and also provide t...

READ MORE...
Tuesday, March 23, 2010

Limeade Raises $3M

Bellevue-based Limeade, which runs employee wellness and health monitoring services, announced today that the firm has raised $3M in a financing round today. Source of the new funding was not disclosed. The firm also said that it has added ...

READ MORE...
Wednesday, March 17, 2010

Cheetah Medical Raises $20M

Cheetah Medical, a developer of noninvasive hemodynamic and cardiac output monitoring technology, said this week that it has raised $20M in a venture round. The firm, which has its U.S. headquarters in Portland, and international headquarte...

READ MORE...
Monday, March 15, 2010

FiatLux Imaging Names CEO

Redmond-based FiatLux Imaging, a developer of an Internet-based service for storing and sharing medical imaging data, announced that it has named Max Lyon as its CEO. Lyon has served as CEO and President of BioControl Systems, Bainbridge Sc...

READ MORE...
Thursday, March 11, 2010

Edge EHR Buys Software Firm

Seattle-based Edge EHR Corp., a developer of electronic health records software, said Wednesday that it has signed a letter of intent to acquire Goal Software, Inc., based in Green Bay, Wisconsin. Financial terms ofthe acquisition were not ...

READ MORE...
Wednesday, March 10, 2010

DeltaPoint Looks To Accelerate Product Development With Prize

Portland, Oregon-based DeltaPoint is planning to accelerate its regulatory, product development and market education efforts with the recent $170,000 the firm garnered at last week's OEN Angel Oregon 2010 Launch State investment competition...

READ MORE...
Tuesday, March 9, 2010

Institute for Systems Biology Gets $6M From VC

Seattle nonprofit research center The Institute for Systems Biology said Monday that it has received a $6M gift from an un-named California venture capitalist and philanthropist, to support the organization. According to the ISB, the fundin...

READ MORE...
Thursday, February 25, 2010

OncoGenex Loses CFO

Bothell-based OncoGenex Pharmaceuticals, a firm developing and commercializing cancer therapies, said late Wednesday that its CFO, Steve Anderson, is leaving the firm. The company said that the company has launched a search for a new CFO. O...

READ MORE...
Tuesday, February 2, 2010

Microsoft Completes Sentillion Buy

Redmond-based Microsoft announced this morning that it has completed its acquisition of Sentillion, a developer of software for the healthcare industry. Microsoft said that Sentillion becomes part of its Microsoft Health Solutions Group, an...

READ MORE...
Friday, December 11, 2009

Dendreon Names COO

Seattle-based biotech Dendreon said Thursday that it has named Hans Bishop as the firm's Chief Operating Officer. Bishop joins the company from Bayer, where he was president of that firm's specialty medicine business. Dendreon said that Bis...

READ MORE...
Thursday, December 10, 2009

Microsoft Buys Sentillion

Microsoft said Thursday that it is acquiring Sentillion, a developer of identity and access management technology for the healthcare industry. Financial terms of the buy were not disclosed. According to Microsoft, it will combine Sentillion...

READ MORE...
Thursday, December 10, 2009

Kineta Gets University Grant

Seattle-based Kineta, a developer of drugs targeted at autoimmune and viral diseases, said this morning that its development partner, Dr. K. George Chandy of the University of California, Irvine, has received a grant related to the firm's l...

READ MORE...
Friday, December 4, 2009

ZymoGenetics Whacks 52

Seattle-based ZymoGenetics, a developer of pharmaceutical products, reported in a filing yesterday that it has laid off 52 employees, or approximately 15% of its staff, as a part of an effort to "further align" the firm with opportunities. ...

READ MORE...
Monday, November 30, 2009

EndoGastric Solutions Gains $21.5M

EndoGastric Solutions, a developer of treatments for gastroesophageal reflux disease (GERD) and other GI disorders which has facilities in Redmond, said late last week that it has raised $21.5M in a Series E financing. The firm said the fun...

READ MORE...
Wednesday, November 18, 2009

NanoString In Collaboration With Broad Institute

Seattle-based NanoString Technologies revealed this morning that it is in a research collaboratoin with the Broad Institute of MIT and Harvard. According to NanoString, the collaboration includes the investigation of molecular networks invo...

READ MORE...
Monday, November 16, 2009

Trubion Pharmaceuticals Shakes Up Execs

Seattle-based Trubion Pharmaceuticals is in the midst of an executive shakeup, saying Monday that Peter Thompson, the firm's Co-founder, President, CEO, and Chairman, has retired to "pursue other interests." The firm said that Steven Gillis...

READ MORE...
Thursday, November 12, 2009

Cardiac Science In Development Partnership

Bothell-based Cardianc Science, a developer of automated external defibrillators (AEDs) and other cardiac monitoring devices, said today that it has linked with Cambridge Heart, a developer of noninvasive diagnostics tests for cardiac disea...

READ MORE...
Monday, November 9, 2009

SonoSite Expands iPhone App

Bothell-based SonoSite, a developer of handheld ultrasound devices, said today that it has expanded the firm's SonoAccess iPhone application, to include musculoskeletal specialties. SonoSite initially introduced its iPhone app in June. The ...

READ MORE...
Friday, November 6, 2009

Report: 77,000 Life Sciences Jobs In Washington State

A report released Friday by the We Work for Health finds that there are a total of 77,000 jobs now in Washington state. The Washington Life Sciences Economic Impact Study found that life sciences are directly responsible for 22,349 jobs in ...

READ MORE...
Monday, October 19, 2009

SonoSite Settles With GE

Bothell-based SonoSite, a developer of portable ultrasound instruments, announced Monday that it has resolved a set of patent litigation suits with General Electric. The firm said that GE will pay SonoSite $21M, plus an ongoing royalty on U...

READ MORE...
Monday, October 12, 2009

Dendreon Expands Board

Seattle-based Dendreon announced today that it has added Ian Clark and Pedro Granadillo to the firm's board of directors. Clark is Head of Global Product Strategy and Chief Marketing Officer at Roche, Pharma Division, and is becoming CEO of...

READ MORE...
Monday, October 12, 2009

Endogastric Solutions Gets $2.0M

Redmond-based Endogastric Solutions, a developer of medical devices for treating gastroesophageal reflex disease (GERD), has raised $2.0M in a funding round, according to a regulatory filing from the firm last week. According to the filing,...

READ MORE...
Monday, October 12, 2009

Clinicient Gets $250K More

Portland-based Clinicient, which develops outsourced physical therapy billing software, has raised another $250,000, according to a regulatory filing from the firm last week. The additional funding comes on top of $2.0M raise in March of th...

READ MORE...
Thursday, October 8, 2009

Uptake Medical Gets $4.5M More

Seattle-based Uptake Medical, a developer of treatments for emphysema, has raised $4.5M in an ongoing, $13.3M round, according to a regulatory filing from the firm today. No details on the funding have been announced. The filing indicates t...

READ MORE...
Monday, October 5, 2009

SonoSite Rolls New Software

Bothell-based SonoSite, a developer of ultrasound systems, said today that it has rolled out a new software program targeted at managing ultrasound workflow. The firm said its new SonoSite Workflow Solution provides physicians with the abil...

READ MORE...
Wednesday, September 30, 2009

Spiration Gets $7M

Seattle-based Spiration, a maker of medical devices for treating emphysema, has raised $7M in a convertible debt round, according to a regulatory filing. According to reports, the funding came from Olympus Medical Systems. Spiration is back...

READ MORE...
Tuesday, September 22, 2009

Integrative Diagnostics Takes $7.5M

Seattle-based Integrative Diagnostics, a firm developing technology to detect cancer in the bloodstream, has raised $7.252M as part of an ongoing, $30.1M fundraising effort, according to a regulatory filing from the firm last week. No detai...

READ MORE...
Thursday, September 17, 2009

Calypso Medical Raises $50M

Seattle-based Calypso Medical Technologies said Thursday that it has raised $50M in a venture funding round. The firm, which develops medical technology for tracking tumors, said that the round was led by Skyline Ventures and Frazier Health...

READ MORE...
Thursday, September 3, 2009

Archus Orthopedics Goes Under

Redmond-based Archus Orthopedics is shutting down its operations, as the firm failed to raise a funding round, according to a legal notice from the firm. Archus was venture backed by MPM Capital, InterWest Partners, Polaris Venture Partners...

READ MORE...
Tuesday, August 11, 2009

Dendreon Expands Near Atlanta

Seattle-based Dendreon, which is developing treatments for advanced prostate cancer, said Monday that the firm is expanding in Atlanta with a new manufacturing facility. The firm said it has signed a lease agreement with Majestic Realty Co....

READ MORE...
Friday, August 7, 2009

Confirma Acquired By Milwaukee Firm

Seattle-based Confirma, a developer of software used for helping radiologists analyze MRI and other images, has been acquired by Milkwaukee-based Merge Healthcare. Merge said the all-stock transaction is worth approximately $22M, or 5.6 mi...

READ MORE...
Wednesday, August 5, 2009

Oncothyreon Gets $15M in PIPE

Seattle-based Oncothyreon, a publicly held biotech firm developing treatments for cancer, has scored $15M in a private placement in the publicly held firm. According to Oncothyreon, it is seeling 2.28 million shares of its common stock and ...

READ MORE...
Friday, July 24, 2009

OncoGenex Pharmaceuticals Raises $9.5M

Bothell-based OncoGenex Pharmaceuticals, a developer of cancer treatments, announced this morning that it has raised $9.5M in a registered direct offering to institutional investors. The publicly held firm, which trades as OGXI on the Nasda...

READ MORE...
Monday, July 20, 2009

OncoGenex Gets $9.5M In PIPE

Bothell-base OncoGenex Pharmaceuticals, which is focusing on treatments for cancer, disclosed Monday that the firm has inked a deal with institutional investors, where those investors will buy 475,000 shares of its common stock at $20 per s...

READ MORE...
Monday, July 20, 2009

Yecuris Gains $1.25M

Portland-based Yecuris, a biotech startup spun out of Oregon Health and Science University, has raised $1.25M in a funding round, according to a regulatory filing from the firm today. According to the filing, the equity fundraising came fro...

READ MORE...
Wednesday, July 15, 2009

Bio Architecture Lab Gets $3.3M

Seattle-based Bio Architecture Lab, a startup out of the University of Washington, has raised $3.3M in an equity funding round, according to a regulatory filing from the firm today. Details on the funding have not been released by the compa...

READ MORE...
Wednesday, July 15, 2009

OVP Ventures Into Limerick BioPharma

Seattle venture capital firm OVP Venture Partners is the lead in the funding of a San Francisco firm developing biopharmaceuticals, according to the firm, Limerick BioPharma. Limerick, which develops compounds for reducing side effects in d...

READ MORE...
Monday, July 13, 2009

Kryptiq Adds NASA

Portland-based Kryptiq, a provider of software for healthcare collaboration, disclosed today that the firm has signed on the National Aeronautics and Space Administration (NASA) Space Medicine Division. Krptiq said that NASA's flight surgeo...

READ MORE...
Wednesday, July 8, 2009

EndoGastric Solutions Gains $7.5M

Redmond-based EndoGastric Solutions, a developer of medical devices for treating gastroesophageal reflex disease (GERD), has raised another $3.75M in funding for the firm, according to a regulatory filing from the firm today. The round come...

READ MORE...
Wednesday, July 1, 2009

PhysioSonics Confirms $2.0M Fundraising

Bellevue-based PhysioSonics officially confirmed the firm's recent $2.0M financing in a second tranche of a Series A this morning, saying that the funding came from an unnamed strategic investor. The firm said the follow on investment bring...

READ MORE...
Thursday, June 25, 2009

SonoSite Links To iPhone

Bothell, Washington-based SnoSite, a manufacturer of handheld ultrasound devices for the medical market, said Wednesday that the firm has rolled out a new, iPhone application which helps medical professionals access to information videos on...

READ MORE...
Wednesday, June 24, 2009

Spacelabs Sells Clinical Trials Services Division

Issaquah, Wash.-based Spacelabs Healthcare has sold its Clinical Trials Services division to Medifacts International Inc. of Rockville, Md., Medifacts announced this morning. Financial terms of the transaction were not disclosed. Spacelabs ...

READ MORE...
Friday, June 19, 2009

TranSenda Releases Clinical Trial Management Software

Bellevue, Washington-based TranSenda, a developer of software for the clinical trial market, said Thursday that the firm has created a new product focused on improving access to centralized clinical trial data. The firm said its new product...

READ MORE...
Tuesday, June 9, 2009

SonoSite Buys CardioDynamics

Bothell, Washington-based SonoSite, a publicly held firm developing ultrasound equipment, said Tuesday afternoon that it is in an agreement to acquire CardioDynamics International Corporation. According to SonoSite, the deal is worth approx...

READ MORE...
Tuesday, June 9, 2009

NanoString Technologies Gets $30M

Seattle-based NanoString Technologies, a developer of life sciences technology for characterizing biological samples, said today that the firm has raised $30M in a Series C equity financing. According to the firm, the round was led by Claru...

READ MORE...
Monday, June 1, 2009

Microsoft Buys Rosetta Biosoftware

Redmond-based Microsoft announced Monday that the firm has signed an agreement with biotech giant Merck & Co., to acquire Rosetta Biosoftware, a developer of genetic data management software. Financial terms of the buy were not disclosed. A...

READ MORE...
Monday, June 1, 2009

Mediquest Therapeutics Gets $2.3M

Bellevue-based Mediquest Therapeutics, which is developing products for the topical treatment of inflammatory and infectious diseases, has apparently raised $2.3M of an ongoing, $15M equity funding round, according to a regulatory filing fr...

READ MORE...
Wednesday, May 20, 2009

Pathway Medical Closes Series D Funding

Kirkland-based Pathway Medical Technologies disclosed Wednesday that the firm has closed its Series D investment round, adding new investor WRF Capital to the $42.5M funding. Pathway said that WRF invested $1.5M as part of its previously an...

READ MORE...
Wednesday, May 20, 2009

Click Commerce Wins Maryland School of Medicine

Beaverton, Oregon-based Click Commerce, a provider of Web-based applications that assist with health care research, revealed Wednesday that a prominent public school will use its eResearch Portal software. The financial impact of the custom...

READ MORE...
Tuesday, May 19, 2009

CoAptus Gains $3M

Redmond-based CoAptus Medical, which is developing non-implant, energy-based device to treat the heart condition patent foramen ovale (PFO), has raised $3.0M in an equity round of funding, according to a regulatory filing from the firm. CoA...

READ MORE...
Monday, May 18, 2009

Xori Spins Out Of Accelerator

Seattle-based XORI, a biotech startup, has spun out of Accelerator Corp.. According to Accelerator, Xori is focused on technology for the rapid discovery and development of monoclonal antibodies (MAbs). Investors in the Series A funding inc...

READ MORE...
Monday, May 11, 2009

Proteotech Nabs $500K In Debt Funding

Kirkland, Washington-based Proteotech has scored $519,401 in debt financing, according to a recent regulatory filing by the firm. Source of the debt financing was not disclosed. Proteotech develops treatments for Alzheimer's disease, Parkin...

READ MORE...
Friday, May 8, 2009

Report: Aspen Medtech Shuts Down

Bellevue-based Aspen Medtech, a developer of medical device technology, has shut down, according to a report from VentureWire. Aspen Medtech was founded by Daniel Hawkins; the firm's executives were all previously at Seattle Medical Technol...

READ MORE...
Friday, May 8, 2009

Targeted Genetics Mulls Bankruptcy

Seattle-based Targeted Genetics could be headed for bankruptcy. The publicly traded biotechnology firm suggested such could be a possibility in its first-quarter earnings report, which it made public Thursday. B.G. Susan Robinson, Targeted ...

READ MORE...
Tuesday, May 5, 2009

Calistoga Pharmaceuticals Raises $30M More

Seattle-based Calistoga Pharmaceuticals, which is developing treatments for cancer and inflammatory diseases, said Tuesday that it has raised $30M in a Series B funding round. Calistoga said that the funding came from Alta Partners, Amgen V...

READ MORE...
Monday, May 4, 2009

ZymoGenetics Licenses Products To Seattle Life Sciences

Seattle-based ZymoGenetics reported Monday that it has licensed the rights to eight of the firm's early stage product candidates to Seattle Life Sciences. Financial impact of the deal was not disclosed. According to Zymogenetics, it is enti...

READ MORE...
Thursday, April 30, 2009

ZymoGenetics Whacks 161 Employees

Seattle-based ZymoGenetics, which is developing protein-based drugs, said Wednesday that it has cut 161 employees, or 32 percent of its staff. The firm said the move will save it approximately $30M in annual operating expenses. The firm sai...

READ MORE...
Wednesday, April 22, 2009

Kryptiq Sells Software Line

Portland-based Kryptiq, publisher of a doctor-to-patient collaborative platform, announced Tuesday that it has sold its Choreo health plan network management software to Portico Systems. Financial terms of the transaction were not disclosed...

READ MORE...
Tuesday, April 14, 2009

Cell Therapeutics Gets $15M In PIPE

Cell Therapeutics announced late Monday that an institutional investor has purchased $15 million of Series 1 Preferred Stock and associated warrants and might buy up to $5 million more within the next 60 days. CTI, which develops therapies ...

READ MORE...
Monday, April 6, 2009

CollegeNET Targets Medical Records

Portland, Oregon-based CollegeNET, a developer of web-based software for educational institutions, said today that the firm has created a new division focused on medical records automation. CollegeNET said its new Medical Records division w...

READ MORE...
Friday, April 3, 2009

Cell Therapeutics Dodges Delisting

Seattle-based Cell Therapeutics, which is developing cancer treatment drugs, said Friday morning that the firm has received a notice from the NASDAQ, saying that it is in full compliance with requirements for continued listing on the NASDAQ...

READ MORE...
Tuesday, March 31, 2009

Rosetta Biosoftware Signs Stanford

Seattle-based Rosetta Biosoftware, a maker of products for genetic data management and analysis, said Tuesday that the firm has signed on Stanford University as a licensee. According to the firm, Stanford will use the firm's products as par...

READ MORE...
Monday, March 30, 2009

Pathway Medical Gains $40M

Kirkland, Washington-based Pathway Medical Technologies announced this morning that the firm has raised $40M in a Series D funding round. According to the firm, the funding came from Forbion Capital Partners, HLM Venture Partners, Latterell...

READ MORE...
Monday, March 23, 2009

MDRNA In License Deal With Novartis

Bothell, Wash.-based MDRNA, a biotechnology firm developing products based on RNA interference, said Monday that it is in a licensing agreement with Novartis. According to MDRNA, Novartis will license its liposomal technology platform for s...

READ MORE...
Monday, March 2, 2009

Cell Therapeutics Cuts 62 in Italy

Seattle-based Cell Therapeutics, which is developing chemotherapy drugs, said Friday that it is closing its European operations and laying off a total of 62 employees. According to Cell Therapeutics, the move is expected to save it $14M in ...

READ MORE...
Tuesday, February 3, 2009

MolecularMD Receives $3M Investment

A Florida-based venture capital firm announced recently that it has invested $3 million into MolecularMD Corp. According to Ballast Point Ventures, MolecularMD will use the funds to finance expansion of its assay portfolio and corporate inf...

READ MORE...
Friday, January 30, 2009

Report: Ekos Gets $12.5M

Bothell, Washington-based Ekos, which develops medical devices for treating blood clots, has raised $12.5M in a round, according to reports. According to Xconomy, Ekos raised the Series D funding from Crown Venture Fund, in a deal which als...

READ MORE...
Wednesday, January 28, 2009

Omeros Gets $3.1M

Seattle-based Omeros reported Wednesday that the firm has gained $3.1M in a second tranche of equity and grant funding, for the firm's candidates for the treatment of schizophrenia. The firm said the funding came from The Stanley Medical R...

READ MORE...
Thursday, January 15, 2009

Cardiac Sciences Cuts Staff

Bothell, Washington-based Cardiac Science, a developer of defibrillators, electrocardigraph devices, and other medical equipment, said late Wednesday that it is cutting approximately 12% of its current staff, and reducing other expenses. Th...

READ MORE...
Wednesday, January 7, 2009

Omeros Scores Research Grant

Seattle-based Omeros has scored a research grant from the Michael J. Fox Foundation, the firm said Tuesday, worth $465,000. The pharmaceuticals developer said that the grant is a part of an effort to treat Parkinson's disease with its compo...

READ MORE...
Monday, January 5, 2009

Northstar Neuroscience Shuts Down

Seattle-based Northstar Neuroscience said late Monday morning that the firm plans to shut down, and will liquidate the company's assets. The firm, which was looking to develop medical devices to treat major depressive disorder, said its boa...

READ MORE...
Friday, December 19, 2008

Oncothyreon Sells Off Business Line To Merck

Seattle-based Oncothyreon, a developer of cancer treatments, said Thursday that it has sold off a product line to Merck, in a deal worth $13M. Oncothyreon said it sold manufacturing rights to Stimuvax to Merck, via Merck's Canadian affiliat...

READ MORE...
Friday, December 19, 2008

Kryptiq Gains Patent

Portland-based Kryptiq Corp. announced Thursday that it has scored a patent from the U.S. Patent and Trademark Office. The firm, which operates and information network for patient data, said the patent covers its technique for encrypting an...

READ MORE...
Friday, December 19, 2008

Life Sciences Discovery Fund Gives $4.7M To Vaccine Research

Seattle-based Washington Life Sciences Discovery Fund (LSDF) said this week that it has awarded nearly $4.7M to the Washington Vaccine Alliance (WAVA), for a program to help research new vaccines for E. coli, herpes and syphilis. The progra...

READ MORE...
Wednesday, November 12, 2008

Cardiac Sciences Shuffles Board

Bothell, Wash.-based biopharmaceutical firm Cardiac Science Corp. reported Tuesday that it has appointed a new board member and accepted the resignation of two others. The company said the changes, which will leave the board with seven dir...

READ MORE...
Thursday, October 23, 2008

Merck to Close Seattle Research Center

Merck & Co. Inc. announced Wednesday that it plans to close its basic research facility in Seattle's South Lake Union district by the end of 2009. The pharmaceutical manufacturer said the impending closure is part a global restructuring eff...

READ MORE...
Wednesday, September 24, 2008

Omeros Gets $20M In Debt

Seattle-based Omeros, which is developing biopharmaceuticals for treating inflammation and central nervous system disorders, said Wednesday that it has established a $20M, debt facility with BlueCrest Capital Finance. Omeros said that the d...

READ MORE...